Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer
- 1 November 2005
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 23 (6) , 423-430
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- AORTIC REPLACEMENT DURING POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTIONJournal of Urology, 2001
- SALVAGE SURGERY OF CHEMOREFRACTORY GERM CELL TUMORS WITH ELEVATED TUMOR MARKERSJournal of Urology, 2000
- Surgery as salvage therapy in chemotherapy‐resistant nonseminomatous germ cell tumoursBritish Journal of Urology, 1998
- Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy aloneUrology, 1997
- Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.Journal of Clinical Oncology, 1995
- Surgical resection in patients withnonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapyUrology, 1994
- Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections.Journal of Clinical Oncology, 1993
- Surgical salvage of chemorefractory germ cell tumors.Journal of Clinical Oncology, 1993
- Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markersCancer, 1992
- Elevated Serum Tumor Markers in Patients with Testicular Cancer after Induction Chemotherapy due to a Reservoir of Markers in Cystic Differentiated Mature TeratomaJournal of Urology, 1991